Search results
MicroRNAs for Cardiac Regeneration
Author(s):
Camilla Olianti
,
Mauro Giacca
Added:
6 months ago
Review Article
Ventricular Tachycardia After Cardioversion
Author(s):
Eiad Habib
,
Mahmoud Abdelnabi
,
Ramzi Ibrahim
,
et al
Added:
4 months ago
Case Report
Added:
5 months ago
Source:
Radcliffe Cardiology
New analyses from the ATTRibute-CM trial show that the transthyretin (TTR) stabiliser acoramidis provides consistent clinical benefits in patients with both wild-type (ATTRwt-CM) and variant (ATTRv-CM) transthyretin amyloid cardiomyopathy.1 The findings include data from the main 30-month trial and its ongoing 42-month open-label extension (OLE).Acoramidis is an orally administered, small…
View more
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
1 year ago
Keep up-to-date with our video collection covering the American Heart Association's 2024 Scientific Sessions in Chicago. For expert insights on the hottest late-breaking and featured science trials, tune in to our collection.To catch reviews on the most awaited trials, watch our recurring series View From the ThoraxCenter, hosted by Prof Nicolas Van Mieghem andDr Joost Daemen (Thoraxcenter,…
View more
Patrick W Serruys
Job title: Professor of Interventional Medicine
Author
Ep 141: From EMPA-REG to Clinical Practice: Mastering SGLT2 Inhibitors in Modern Cardiology
Added:
7 months ago
Podcast Episode
PAP Therapies for HF: What Do the Trials Tell Us?
Author(s):
Jan Pec
,
Michael Arzt
Added:
4 months ago
Review Article
James C Moon
Research Area(s) / Expertise:
Job title: Clinical Director of Imaging
Author
Carlo Di Mario
Research Area(s) / Expertise:
Job title: Full Professor of Cardiology
Author
Added:
1 year ago
Source:
ESC Congress
The European Society of Cardiology has revealed 12 Hot-Line trial sessions to be presented at the end of August.ESC Congress 2024 will be held from the 30thAugust to the 2nd September at the ExCel Center in London. View the full programme here.Don't miss our video collection covering late-breaking data from ESC Congress 2024, including a preview of the most anticipated trials in View from the…
View more